Join us at Next Generation Dx Summit 2016!
Biological Dynamics' CEO, Raj Krishnan will be sharing his perspectives on validating clinical utility of cancer diagnostic solutions in Clinical Utility and Cost Effectiveness of Predictive Cancer Biomarkers panel discussion at 3:35 PM on Friday, August 26.
Please join us at 7AM at the conference site, as Biological Dynamics CEO presents the latest company developments at Molecular Med Tri-Con 2016.
At the symposium renowned speakers from the fields of science and business will investigate topics, such as biomarkers, biobanking, sample archival, personalized medicine and monitoring from a holistic perspective. Mark Adler, MD, Chairman of SAB, will present clinical perspectives on treatment response monitoring using Biological Dynamics technology.